5 Aug 2022 , 05:45 PM
Net profit of Mangalam Drugs and Organics declined 32.13% to Rs 3.00 crore in the quarter ended June 2022 as against Rs 4.42 crore during the previous quarter ended June 2021. Sales rose 2.79% to Rs 107.70 crore in the quarter ended June 2022 as against Rs 104.78 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 107.70 | 104.78 | 3 |
| OPM % | 9.62 | 9.88 | – |
| PBDT | 6.83 | 7.91 | -14 |
| PBT | 4.23 | 5.52 | -23 |
| NP | 3.00 | 4.42 | -32 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
